Source Paper
The Microtubule-Stabilizing Agent, Epothilone D, Reduces Axonal Dysfunction, Neurotoxicity, Cognitive Deficits, and Alzheimer-Like Pathology in an Interventional Study with Aged Tau Transgenic Mice
Bin Zhang, Jenna Carroll, John Q. Trojanowski, Yuemang Yao, Michiyo Iba et al.
Journal of Neuroscience • 2012
Cognitive Performance Testing
Objective: Evaluation of cognitive performance and behavioral deficits in aged PS19 mice treated with epothilone D to assess whether MT-stabilizing treatment improves cognitive function in a transgenic tau pathology model
This is a Cognitive Performance Testing protocol using mouse as the model organism. The procedure involves 3 procedural steps, 1 materials. Extracted from a 2012 paper published in Journal of Neuroscience.
Model and subjects
mouse • PS19 • unknown • aged • not specified
Study window
Estimated timing pending
Core workflow
Animal Treatment • Cognitive Performance Assessment • Behavioral Deficit Evaluation
Primary readouts
- Cognitive performance improvement
- Axonal dystrophy reduction
- Axonal microtubule density increase
- Fast axonal transport improvement
Key equipment and reagents
Verified items
0
Direct vendor links
0
Use this page as an execution guide, then fall back to the source paper whenever you need exact exclusions, dosing details, or assay-specific caveats.
Confirm first
- Verify the animal model, intervention setup, and collection timepoints against the source paper.
- Check that every direct vendor link matches the exact specification your lab plans to run.
Use the page like this
- Work through the protocol steps in order and use the inline vendor chips only when you need to source or verify an item.
- Jump to Experimental Context for readouts, data shape, and analysis flow before planning downstream analysis.
Protocol Steps
Start here. The step list is optimized for running the experiment, with direct vendor links available inline when you need to source a cited item.
Animal Treatment
Aged PS19 mice with existing tau pathology were treated with epothilone D
Note: Treatment was interventional in nature, administered to mice with pre-existing tau pathology
View evidence from paper
“interventional study of the brain-penetrant MT-stabilizing agent, epothilone D (EpoD), in aged PS19 mice with existing tau pathology”
Cognitive Performance Assessment
Cognitive performance was evaluated in treated and control PS19 mice
Note: Specific cognitive tests and behavioral assessment methods are not detailed in the provided text
View evidence from paper
“EpoD treatment reduced axonal dystrophy and increased axonal MT density in the aged PS19 mice, which led to improved fast axonal transport and cognitive performance”
Behavioral Deficit Evaluation
Behavioral deficits related to tau pathology were assessed in treated mice
Note: Mice had related behavioral deficits at baseline due to tau pathology
View evidence from paper
“aged PS19 mice with existing tau pathology and related behavioral deficits”